Ryan Fischesser - 20 Dec 2021 Form 4 Insider Report for Caribou Biosciences, Inc. (CRBU)

Signature
/s/ Barbara G. McClung as, attorney-in-fact
Issuer symbol
CRBU
Transactions as of
20 Dec 2021
Net transactions value
+$3,056
Form type
4
Filing time
21 Dec 2021, 16:23:26 UTC
Previous filing
12 Oct 2021
Next filing
12 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRBU Common Stock Purchase $3,056 +1,136 +1.1% $2.69 101,695 20 Dec 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBU Option to purchase Common Stock Exercise of in-the-money or at-the-money derivative security $0 -1,136 -13% $0.000000 7,384 20 Dec 2021 Common Stock 1,136 $2.69 Direct F2, F3
transaction CRBU Option to purchase Common Stock Award $0 +40,000 $0.000000 40,000 20 Dec 2021 Common Stock 40,000 $15.16 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired pursuant to the exercise of a stock option, as reported in Table II below.
F2 The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021.
F3 The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on January 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
F4 The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on December 20, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.